Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Psychedelics researchers balance trippyness with scientific rigor after history of legal and cultural controversy – podcast
(THE CONVERSATION) As research into psychedelics and their medical uses makes a comeback, scientists are having to deal with the legacy – both scientific and social – of a 40-year nearly total freeze ...
Psychology Today3d
How to Say No to Dominant Leaders
High-conflict leaders exploit cognitive biases to dominate. Science-backed strategies reveal how to neutralize their tactics—without losing your cool.